The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

39 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase.EBI
University of Texas
Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition.EBI
University of Texas
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.EBI
University of Texas
Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines.EBI
University of Texas
Inhibition of human dimethylarginine dimethylaminohydrolase-1 by S-nitroso-L-homocysteine and hydrogen peroxide. Analysis, quantification, and implications for hyperhomocysteinemia.EBI
University of Texas
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme.EBI
University of Texas
1,2,3-trisubstituted cyclopropanes as conformationally restricted peptide isosteres: application to the design and synthesis of novel renin inhibitors.EBI
University of Texas
METHIONINE ADENOSYLTRANSFERASE 2a (MAT2A) INHIBITORS AND USES THEREOFBDB
Insilico Medicine IP
UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITORBDB
Simcere Zaiming Pharmaceutical Co.
ISOINDOLINONE COMPOUNDSBDB
Monte Rosa Therapeutics
COMPOUNDS FOR THE TREATMENT OF SARSBDB
Purdue Research Foundation
5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereofBDB
Biosplice Therapeutics
CDK inhibitors and their use as pharmaceuticalsBDB
Prelude Therapeutics
Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitorsBDB
Venenum Biodesign
Therapeutic compounds and methods of use thereofBDB
Ligature Therapeutics
Broad spectrum inhibitors of filovirusesBDB
Microbiotix
Cycloalkyl-diamines for the treatment of inflammationBDB
Medisynergics
Compounds that inhibit Mcl-1 proteinBDB
Amgen
Phenoxymethyl derivativesBDB
Hoffmann-La Roche
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamidesBDB
Pfizer
Inhibitors of hepatitis C virus replicationBDB
Merck Sharp & Dohme
Tetrahydroquinoline derivatives as P2X7 receptor antagonistsBDB
Raqualia Pharma
ArylquinazolinesBDB
Merck Patent
Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitorsBDB
Principia Biopharma
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBDB
Bristol-Myers Squibb
Imidazolyl kinase inhibitors and uses thereofBDB
Dana-Farber Cancer Institute
Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2BDB
Merck Sharp & Dohme
Heterocyclic inhibitors of ATR kinaseBDB
University Of Texas
Pyrazole derivatives as MALT1 inhibitorsBDB
Janssen Pharmaceutica
Triazolo-pyrimidine compounds and uses thereofBDB
TBA
Bicyclic heterocyclic compoundBDB
Mitsubishi Tanabe Pharma
Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitorsBDB
Leo Pharma
Compounds and their use for reducing uric acid levelsBDB
Acquist
Derivatives of sobetiromeBDB
Oregon Health & Science University
Sulfur-containing compounds targeting vesicular acetylcholine transporterBDB
Washington University
3-amino-pyridines as GPBAR1 agonistsBDB
Hoffmann-La Roche
Pyrrolopyrimidine compounds and uses thereofBDB
Hutchison Medipharma
RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist.BDB
Roche Bioscience
Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.BDB
Merck Research Laboratories